← Eichor
Condition: Recurrent Bladder Carcinoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Recurrent Bladder Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma
Phase 2 · 2 location(s) · Mabwell (Shanghai) Bioscience Co., Ltd. · NCT06823427Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence
Phase 2 · 1 location(s) · University of California, Irvine · NCT06682728Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive B
Phase 3 · 6 location(s) · Verity Pharmaceuticals Inc. · NCT05037279Robotic Radical Cystectomy Outcomes
Phase N/A · 1 location(s) · University of Florence · NCT04900558Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recu
Phase 3 · 1 location(s) · Chengdu CoenBiotech Co., Ltd · NCT06241755To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With H
Phase 1 · 2 location(s) · Shenzhen Xinhe Biomedical · NCT07594964Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/
Phase N/A · 1 location(s) · University of Washington · NCT01050504PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bl
Phase 1 · 1 location(s) · University of California, Davis · NCT06173349A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Mi
Phase N/A · 1 location(s) · Peking University First Hospital · NCT06991868Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical Instillation
Phase N/A · 2 location(s) · Jahn Ferenc South Pest Teaching Hospital · NCT06719232Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer
Phase 4 · 8 location(s) · Jakob Kristian Jakobsen · NCT06781879Outpatient Laser Ablation of Recurrent Non-muscle Invasive Bladder Cancer
Phase N/A · 1 location(s) · Jørgen Bjerggaard Jensen · NCT05337397Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06167356Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Phase N/A · 6 location(s) · University of Washington · NCT07225127Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
Phase N/A · 3 location(s) · Early is Good Inc. · NCT05982561Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder Cancer
Phase 2 · 1 location(s) · Paul Toren · NCT07420517A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscl
Phase 2 · 1 location(s) · Roswell Park Cancer Institute · NCT06733363Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER Trial
Phase N/A · 1 location(s) · OHSU Knight Cancer Institute · NCT07726602Analysis of Urinary Methylation Patterns Via Liquid Biopsy as an Early Diagnosis Tool
Phase N/A · 1 location(s) · Regina Elena Cancer Institute · NCT06878027A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients
Phase 1 · 16 location(s) · OncoNano Medicine, Inc. · NCT06022029Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy T
Phase 2 · 134 location(s) · National Cancer Institute (NCI) · NCT06770582Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Inva
Phase 3 · 58 location(s) · Alliance for Clinical Trials in Oncology · NCT07000084Prospective Sample Collection for Cancer of Bladder
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT03973671Impact of Remimazolam on Prognosis After Bladder Cancer Surgery
Phase 4 · 6 location(s) · Peking University First Hospital · NCT04532606Impacts and Testing of the "Multi-domains Active-living Program" in Operable Non-Muscle Invasive Bladder Cancer Patients
NA · 1 location(s) · National Taiwan University Hospital · NCT05739968Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring
Phase N/A · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07514897A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1 · 16 location(s) · IDEAYA Biosciences · NCT07277413Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthra
Phase 1 · 1 location(s) · First Affiliated Hospital of Chongqing Medical University · NCT06766266Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma
Phase 2 · 1 location(s) · Nagoya University · NCT06983210Effects of Microbiological and Immunological Factors on the Lower Urinary Tract
Phase N/A · 1 location(s) · University of Zurich · NCT07494864
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.